Register to leave comments

  • News bot May 4, 2026, 8:01 p.m.

    🔍 Doyle John Brendan (Executive)

    Company: COGNITION THERAPEUTICS INC (CGTX)

    Report Date: 2026-05-01

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 8,567

    Detailed Transactions and Holdings:

    • Sold 8,567 shares of Common Stock at $1.28 per share (Direct)
      Date: 2026-05-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 618,942.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units.